Prostatic cancer
Conditions
Interventions
Case series (Prospective+ Retrospective):None
Sponsors
The second hospital & clinical medical school, Lanzhou university
Eligibility
Sex/Gender
Male
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1. Age = 18 years old; 2. Pathologically confirmed prostate cancer patients; 3. Sign an informed consent form and voluntarily participate in this study; 4. The researchers determine that treatment with revalutamide can be used, or that they have received or are currently receiving revalutamide treatment
Exclusion criteria
Exclusion criteria: 1. The patient is currently participating in other clinical intervention studies; 2. Unable to understand the nature of the research or did not obtain informed consent; 3.The researcher determines other situations that are not suitable for inclusion in the study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety; | — |
Secondary
| Measure | Time frame |
|---|---|
| DOT;TFST;rPFS;MFS;OS; | — |
Countries
China
Contacts
Public ContactYang Li
The second hospital & clinical medical school, Lanzhou university
Outcome results
None listed